Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical henna formulation for itching and wound healing in epidermolysis bullosa
IRCT20150825023753N14Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of henna in dystrophic epidermolysis bullosa (DEB), sponsored by Shiraz University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
henna
03
Conditions
dystrophic epidermolysis bullosa (DEB)
Beyond the preview
Go deeper on IRCT20150825023753N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150825023753N14.